These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30600144)

  • 1. Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels.
    Fukunaga K; Izumi H; Yabuki Y; Shinoda Y; Shioda N; Han F
    J Pharmacol Sci; 2019 Feb; 139(2):51-58. PubMed ID: 30600144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Type Ca
    Xu J; Kawahata I; Izumi H; Fukunaga K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of SAK3, a novel T-type voltage-gated Ca
    Yabuki Y; Matsuo K; Izumi H; Haga H; Yoshida T; Wakamori M; Kakei A; Sakimura K; Fukuda T; Fukunaga K
    Neuropharmacology; 2017 May; 117():1-13. PubMed ID: 28093211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice.
    Yuan D; Cheng A; Kawahata I; Izumi H; Xu J; Fukunaga K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice.
    Xu J; Yabuki Y; Yu M; Fukunaga K
    J Pharmacol Sci; 2018 Aug; 137(4):333-341. PubMed ID: 30196018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App
    Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of T-type Calcium Channels in Regulating Neuronal Function].
    Yabuki Y
    Yakugaku Zasshi; 2020; 140(10):1207-1212. PubMed ID: 32999199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation.
    Yabuki Y; Jing X; Fukunaga K
    Neurochem Int; 2017 Sep; 108():272-281. PubMed ID: 28457878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.
    Wang S; Yabuki Y; Matsuo K; Xu J; Izumi H; Sakimura K; Saito T; Saido TC; Fukunaga K
    PLoS One; 2018; 13(12):e0206986. PubMed ID: 30571684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice.
    Izumi H; Shinoda Y; Saito T; Saido TC; Sato K; Yabuki Y; Matsumoto Y; Kanemitsu Y; Tomioka Y; Abolhassani N; Nakabeppu Y; Fukunaga K
    Neuroscience; 2018 May; 377():87-97. PubMed ID: 29510211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of demetia therapeutics regurating synaptic plasticity].
    Fukunaga K
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):218-222. PubMed ID: 36990796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices.
    Moriguchi S; Shioda N; Yamamoto Y; Tagashira H; Fukunaga K
    J Neurochem; 2012 Apr; 121(1):44-53. PubMed ID: 22251222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type Ca
    Degawa T; Kawahata I; Izumi H; Shinoda Y; Fukunaga K
    J Pharmacol Sci; 2021 May; 146(1):1-9. PubMed ID: 33858649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Treatment with T-Type Calcium Channel Enhancer SAK3 Reduces Cognitive Impairments Caused by Methimazole-Induced Hypothyroidism Via Activation of Cholinergic Signaling.
    Husain N; Yabuki Y; Shinoda Y; Fukunaga K
    Pharmacology; 2018; 101(5-6):309-321. PubMed ID: 29597200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation.
    Yamamoto Y; Shioda N; Han F; Moriguchi S; Fukunaga K
    J Pharmacol Sci; 2013; 121(3):212-26. PubMed ID: 23449490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior].
    Shioda N; Yamamoto Y; Han F; Moriguchi S; Fukunaga K
    Yakugaku Zasshi; 2011 Apr; 131(4):505-11. PubMed ID: 21467789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control mechanism of cognitive function by t-type membrane potential-dependent calcium channel].
    Moriguchi S
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):187. PubMed ID: 22891392
    [No Abstract]   [Full Text] [Related]  

  • 18. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome.
    Janakiraman U; Dhanalakshmi C; Yu J; Moutal A; Boinon L; Fukunaga K; Khanna R; Nelson MA
    Neurobiol Dis; 2020 Sep; 143():105006. PubMed ID: 32622085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease.
    Zhang H; Wu L; Pchitskaya E; Zakharova O; Saito T; Saido T; Bezprozvanny I
    J Neurosci; 2015 Sep; 35(39):13275-86. PubMed ID: 26424877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer's disease and vascular dementia.
    Min D; Guo F; Zhu S; Xu X; Mao X; Cao Y; Lv X; Gao Q; Wang L; Chen T; Shaw C; Hao L; Cai J
    Neurosci Lett; 2013 Mar; 538():60-5. PubMed ID: 23403102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.